AACE Annual Meeting
Diabetes
Rodolfo J. Galindo, MD, FACE
Emory University
Atlanta, Georgia, United States
Disclosure: Abbott Diabetes (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- 12/31/2018); Dexcom (Self) : University Grants/Research Support (Status: Ongoing); Eli Lilly (Self) : Research Grant (Status: Ongoing); Novo Nordisk (Self) : University Grants/Research Support (Status: Ongoing); Sanofi (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Valeritas (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- 12/31/2019); Weight Watchers (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing)
Neda Rasouli, MD
University of Colorado, Colorado, United States
Disclosure: Novo Nordisk (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing)